We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Drug Development Meetings

Drug Development Meetings

May 4, 2006

Join FDAnews Thursday, May 18, for a 90-minute audioconference, "Designing Pregnancy Registries: Strategies to Ensure Maximum Retention and Data Collection" Monica Kumar, associate medical director for Covance, will reveal the common pitfalls that could jeopardize your pregnancy registry, and how to prevent them. On May 24, join FDAnews for "Clinical Trial Billing Under Medicare: Negotiate Trial Budgets to Steer Clear of the OIG." In this 90-minute audioconference with Q&A session, noted attorney Mark Barnes will show you how to negotiate a clinical trial budget that keeps your sites operating and billing in compliance.

May 8-10: Generic Drug Approvals Amsterdam, the Netherlands 31 20 638 28 06 Center for Professional Advancement amsterdam@cfpa.com www.cfpa.com

May 9-10: How to Monitor Clinical Trials for GCP Compliance Dublin, Ireland

(610) 688-1708 The Center for Professional Innovation and Education info@cfpie.com

www.cfpie.com/showitem.aspx?productid=043&source=fdanewsconferencecalendarfree

May 11-12: Complying with the EU Clinical Trial Directive Morristown, NJ (212) 661-3250 PTi international dweinberg@pti-international.com www.pti-international.com

May 15-17: Non-clinical Drug Safety Evaluation & Drug Development Amsterdam, the Netherlands 31 20 638 28 06 Center for Professional Advancement amsterdam@cfpa.com

www.cfpa.com

May 21-24: Outsourcing & Offshoring Clinical Trials

Boston, Mass. (773) 695-9400 Advanced Learning Institute bob@aliconferences.com

www.aliconferences.com

May 22-23: Complying with the EU Clinical Trial Directive Washington, DC (212) 661-3250 PTi international dweinberg@pti-international.com

www.pti-international.com

May 22-24: Skin Product Development Amsterdam, the Netherlands 31 20 638 28 06 The Center for Professional Advancement

amsterdam@cfpa.com www.cfpa.com

May 24: Clinical Trial Billing Under Medicare Negotiate Trial Budgets to Steer Clear of the OIG An audioconference

Your Office (703) 538-7600 http://www.fdanews.com/wbi/conferences/ctbilling.html

May 25-26: Project Management in Drug Development: Phase I and Phase II Clinical Development

San Diego, Calif. (212) 661-3250 PTi international dweinberg@pti-international.com

www.pti-international.com

May 29-31: Microbiological Control & Validation Amsterdam, the Netherlands 31 20 638 28 06 The Center for Professional Advancement amsterdam@cfpa.com www.cfpa.com

May 31: Best Practices in Electronic Data Capture for Clinical Trials Tips to Cut Costs and Increase Efficiency An audioconference Your Office (703) 538-7600 http://www.fdanews.com/wbi/conferences/datacapture.html

June 1-2: Clinical Trials for Pharmaceuticals: Design and Development Boston, Mass. (610) 548-2200 Barnett Educational Services customer.service@parexel.com

www.barnettinternational.com/index-flash.html

KEYWORDS Drug Pipeline Alert

Upcoming Events

  • 08Sep

    Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections

  • 15Sep

    Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis

  • 20Sep

    Building a World-Class Pharmaceutical Advertising and Promotion Review Program

  • 21Sep

    The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval

  • 22Sep

    FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers

  • 11Oct

    1st Annual Quality Management vSummit

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • Hyris T-Cell Test Gains CE-IVD Mark

  • FDA Expands Approval of Bayer’s Nubeqa for Prostate Cancer

  • MicroPort Navibot Receives 510(k) Clearance for Its SkyWalker System

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing